Compounds > xanthine

xanthine and adenosine-5'-(n-ethylcarboxamide)

xanthine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahms, TE; Richard, LF; Webster, RO1
Belardinelli, L; Biaggioni, I; Feoktistov, I; Garland, EM; Goldstein, AE; Wells, JN; Zeng, D1

Other Studies

2 other study(ies) available for xanthine and adenosine-5'-(n-ethylcarboxamide)

ArticleYear
Adenosine prevents permeability increase in oxidant-injured endothelial monolayers.
    The American journal of physiology, 1998, Volume: 274, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Cell Membrane Permeability; Cells, Cultured; Coloring Agents; Endothelium, Vascular; Evans Blue; Humans; Kinetics; Oxidants; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Umbilical Veins; Xanthine; Xanthine Oxidase

1998
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).
    Biochemical pharmacology, 2001, Nov-01, Volume: 62, Issue:9

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Anti-Asthmatic Agents; Cells, Cultured; Humans; Mast Cells; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Receptor, Adenosine A2B; Receptors, Purinergic P1; Structure-Activity Relationship; Vasodilator Agents; Xanthine; Xanthines

2001